SYNEXUS

Serial Number 97516473
Registration 7524149
700

Registration Progress

Application Filed
Jul 22, 2022
Under Examination
Dec 12, 2023
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered
Oct 1, 2024

Trademark Image

SYNEXUS

Basic Information

Serial Number
97516473
Registration Number
7524149
Filing Date
July 22, 2022
Registration Date
October 1, 2024
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 1, 2024
Registration
Registered
Classes
035

Rights Holder

Synexus Clinical Research US, Inc.

03
Address
929 North Front Street
Wilmington, NC 28401

Ownership History

Synexus Clinical Research US, Inc.

Original Applicant
03
Wilmington, NC

Synexus Clinical Research US, Inc.

Owner at Publication
03
Wilmington, NC

Synexus Clinical Research US, Inc.

Original Registrant
03
Wilmington, NC

Legal Representation

Attorney
Kenya Williams

USPTO Deadlines

Next Deadline
1909 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-10-01)
Due Date
October 01, 2030
Grace Period Ends
April 01, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description
Oct 1, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 1, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 29, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 29, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 1, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 31, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 12, 2024 EX1G S SOU EXTENSION 1 GRANTED
Jun 12, 2024 EXT1 S SOU EXTENSION 1 FILED
Jun 12, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 12, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 12, 2024 IUAF S USE AMENDMENT FILED
Dec 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
Sep 8, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Aug 16, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 11, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 11, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2023 GNRT F NON-FINAL ACTION E-MAILED
May 11, 2023 CNRT R NON-FINAL ACTION WRITTEN
May 9, 2023 DOCK D ASSIGNED TO EXAMINER
Aug 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Recruitment and selection services relating to clinical trials, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; business management services in the field of clinical trials, namely, providing information management services; providing marketing services for the medical and pharmaceutical products of others; Collection and compilation of market research information for clinical trials; business information, advisory and consultancy services relating to clinical trials
First Use Anywhere: Dec 31, 2016
First Use in Commerce: Dec 31, 2016

Classification

International Classes
035